stella
beta
A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) — Stella
Home
/
Retinitis Pigmentosa
/
View on ClinicalTrials.gov
Recruiting
Back to Retinitis Pigmentosa trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Australia
CMAX Clinical Research Pty Ltd, Adelaide, South Australia